Claudia Parisi

1.8k total citations · 1 hit paper
47 papers, 1.2k citations indexed

About

Claudia Parisi is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Claudia Parisi has authored 47 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 19 papers in Oncology and 12 papers in Surgery. Recurrent topics in Claudia Parisi's work include Lung Cancer Treatments and Mutations (15 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Lung Cancer Diagnosis and Treatment (6 papers). Claudia Parisi is often cited by papers focused on Lung Cancer Treatments and Mutations (15 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Lung Cancer Diagnosis and Treatment (6 papers). Claudia Parisi collaborates with scholars based in Italy, France and Spain. Claudia Parisi's co-authors include Umberto Volta, Maria Piscaglia, E Fiorini, Francesco Gelsomino, Alessandro Di Federico, Fabrice Barlési, Angela Fabbri, Francesco Tovoli, Andrea De Giglio and Giuseppe Lamberti and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Claudia Parisi

45 papers receiving 1.2k citations

Hit Papers

Anti-TIGIT therapies for solid tumors: a systematic review 2023 2026 2024 2025 2023 25 50 75

Peers

Claudia Parisi
S A Watson United Kingdom
Jonathan White United Kingdom
Say‐June Kim South Korea
Claudia Parisi
Citations per year, relative to Claudia Parisi Claudia Parisi (= 1×) peers Francesco Paolo Pilato

Countries citing papers authored by Claudia Parisi

Since Specialization
Citations

This map shows the geographic impact of Claudia Parisi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudia Parisi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudia Parisi more than expected).

Fields of papers citing papers by Claudia Parisi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudia Parisi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudia Parisi. The network helps show where Claudia Parisi may publish in the future.

Co-authorship network of co-authors of Claudia Parisi

This figure shows the co-authorship network connecting the top 25 collaborators of Claudia Parisi. A scholar is included among the top collaborators of Claudia Parisi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudia Parisi. Claudia Parisi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Belluomini, Lorenzo, Francesca Gattazzo, Caroline Flament, et al.. (2024). 1172O Akkermansia muciniphila-based multi-omic profiling in advanced non-small cell lung cancer. Annals of Oncology. 35. S762–S762. 1 indexed citations
2.
Giglio, Andrea De, Giulia Venturi, Alessandro Di Federico, et al.. (2024). Early monitoring of plasma KRAS G12C with digital PCR predicts antitumor response to immunotherapy or sotorasib in advanced NSCLC: A brief report. SHILAP Revista de lepidopterología. 6. 100161–100161. 3 indexed citations
3.
Reni, Anna, Caroline Flament, Lorenzo Belluomini, et al.. (2024). Impact of microbiota specific circulating memory T cells in response to immunotherapy.. Journal of Clinical Oncology. 42(16_suppl). 2572–2572. 3 indexed citations
4.
Parisi, Claudia, Damien Vasseur, Pernelle Lavaud, et al.. (2024). Personalized Therapy in a Patient With EGFR-Mutated NSCLC Developing Sequential CCDC6-RET Fusion and BRAF V600E Mutation as Bypass Resistance Mechanisms. JTO Clinical and Research Reports. 6(3). 100773–100773.
5.
Giglio, Andrea De, Dario de Biase, Thais Maloberti, et al.. (2024). STK11 mutations correlate with poor prognosis for advanced NSCLC treated with first-line immunotherapy or chemo-immunotherapy according to KRAS, TP53, KEAP1, and SMARCA4 status. Lung Cancer. 199. 108058–108058. 3 indexed citations
6.
Parisi, Claudia, Marco Tagliamento, Benjamin Besse, et al.. (2024). Neoadjuvant immunotherapy strategies for resectable non-small cell lung cancer (NSCLC): Current evidence among special populations and future perspectives. Cancer Treatment Reviews. 131. 102845–102845. 8 indexed citations
7.
8.
Parisi, Claudia, Linda Mahjoubi, Anas Gazzah, & Fabrice Barlési. (2023). TROP-2 directed antibody-drug conjugates (ADCs): The revolution of smart drug delivery in advanced non-small cell lung cancer (NSCLC). Cancer Treatment Reviews. 118. 102572–102572. 15 indexed citations
9.
Parisi, Claudia, Marco Tagliamento, Mihaela Aldea, et al.. (2023). Circulating tumor DNA in clinical trials for solid tumors: Challenges and current applications. SHILAP Revista de lepidopterología. 1. 100007–100007. 10 indexed citations
10.
Parisi, Claudia, et al.. (2023). Anti-TIGIT therapies for solid tumors: a systematic review. ESMO Open. 8(2). 101184–101184. 90 indexed citations breakdown →
11.
Aldea, Mihaela, Claudia Parisi, Luigi Cerbone, et al.. (2021). 1344P Molecular features of young cannabis smokers with advanced non-small cell lung cancer (aNSCLC). Annals of Oncology. 32. S1024–S1025. 3 indexed citations
12.
Federico, Alessandro Di, Andrea De Giglio, Claudia Parisi, et al.. (2021). Programmed Cell Death Protein-1 Inhibitors Versus Programmed Death-Ligand 1 Inhibitors in Addition to Chemotherapy for the First-Line Treatment of Advanced NSCLC: A Systematic Review and Meta-Analysis. JTO Clinical and Research Reports. 2(9). 100214–100214. 3 indexed citations
13.
Gelsomino, Francesco, Giuseppe Lamberti, Claudia Parisi, et al.. (2019). The evolving landscape of immunotherapy in small-cell lung cancer: A focus on predictive biomarkers. Cancer Treatment Reviews. 79. 101887–101887. 47 indexed citations
14.
Alboni, Paoló, et al.. (2017). Bradicardia sinusale e sincope: quale fisiopatologia e quale gestione del paziente?. Giornale italiano di cardiologia. 18(11). 774–780. 2 indexed citations
15.
Lage, Ricardo, Claudia Parisi, Patricia Seoane‐Collazo, et al.. (2015). Lack of Hypophagia in CB1 Null Mice is Associated to Decreased Hypothalamic POMC and CART Expression. The International Journal of Neuropsychopharmacology. 18(9). pyv011–pyv011. 9 indexed citations
16.
Manfredini, Roberto, Fabio Fabbian, Alfredo De Giorgi, et al.. (2014). Heart and lung, a dangerous liaison-Tako-tsubo cardiomyopathy and respiratory diseases: A systematic review. World Journal of Cardiology. 6(5). 338–338. 23 indexed citations
17.
Giorgi, Alfredo De, Fabio Fabbian, Ruana Tiseo, et al.. (2014). Takotsubo cardiomyopathy and endocrine disorders: a mini-review of case reports. The American Journal of Emergency Medicine. 32(11). 1413–1417. 10 indexed citations
18.
Caruso, Rosario Alberto, Emilia Quattrocchi, Giovanni Branca, et al.. (2011). Ultrastructural Descriptions of Heterotypic Aggregation between Eosinophils and Tumor Cells in Human Gastric Carcinomas. Ultrastructural Pathology. 35(4). 145–149. 30 indexed citations
19.
Caruso, Rosario Alberto, et al.. (2011). Mitotic Catastrophe in Malignant Epithelial Tumors: The Pathologist’s Viewpoint. Ultrastructural Pathology. 35(2). 66–71. 19 indexed citations
20.
Volta, Umberto, Alessandro Granito, E Fiorini, et al.. (2007). Usefulness of Antibodies to Deamidated Gliadin Peptides in Celiac Disease Diagnosis and Follow-up. Digestive Diseases and Sciences. 53(6). 1582–1588. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026